Cited by 444Diabetes and associated disordersDiabetes Management and ResearchT-cell and B-cell Immunology

The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study

Open access
the TEDDY Study Group, Krischer, Jeffrey P., Lynch, Kristian F., Schatz, Desmond A., Ilonen, Jorma, Lernmark, Åke, Hagopian, William A., Rewers, Marian J. +6 more·2015·Diabetologia

Abstract

Aims/hypothesis Islet autoantibodies, in addition to elevated blood glucose, define type 1 diabetes. These autoantibodies are detectable for a variable period of time before diabetes onset. Thus, the occurrence of islet autoantibodies is associated with the beginning of the disease process. The age at, and order in, which autoantibodies appear may be associated with different genetic backgrounds or environmental exposures, or both. Methods Infants with HLA-DR high-risk genotypes (DR3/4, DR4/4, DR4/8 and DR3/3) were enrolled and prospectively followed with standardised autoantibody assessments quarterly throughout the first 4 years of life and then semi-annually thereafter. Results Autoantibodies appeared in 549/8,503 (6.5%) children during 34,091 person-years of follow-up. Autoantibodies at 3 (0.1%) and 6 (0.2%) months of age were rare. Of the 549, 43.7% had islet autoantibodies to insulin (IAA) only, 37.7% had glutamic acid decarboxylase autoantibodies (GADA) only, 13.8% had both GADA and IAA only, 1.6% had insulinoma antigen-2 only and 3.1% had other combinations. The incidence of IAA only peaked within the first year of life and declined over the following 5 years, but GADA only increased until the second year and remained relatively constant. GADA only were more common than IAA only in HLA-DR3/3 children but less common in HLA-DR4/8 children. Conclusions/interpretation Islet autoantibodies can occur very early in life and the order of appearance was related to HLA-DR-DQ genotype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00125-015-3514-y

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Birth cohort studies describe a wide range but a surprising peak incidence of islet autoantibody development at 9 months of age, particularly focused on insulin autoimmunity.

    “In addition, birth cohort studies have shed light on the timing of autoantibody development, describing a wide range but a surprising peak incidence of islet autoantibody development at 9 months of age62, particularly focused on insulin autoimmunity.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 15

  1. [1]1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus Diabetes Care 20 1183 1197 9203460
  2. [2]Orban T Sosenko JM Cuthbertson D 2009 Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1 Diabetes Care 32 2269 2274 19741189 PMC2782989
  3. [5]Ilonen J Hammais A Laine AP 2013 Patterns of beta-cell autoantibody appearance and genetic associations during the first years of life Diabetes 62 3636 3640 23835325 PMC3781470
  4. [6]Group TS 2007 The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design Pediatr Diabetes 8 286 298 17850472
  5. [7]2008 The Environmental Determinants of Diabetes in the Young (TEDDY) Study Ann N Y Acad Sci 1150 1 13 PMC2886800 19120261
  6. [8]Hagopian WA Erlich H Lernmark A 2011 The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants Pediatric Diabetes 12 733 743 21564455 PMC3315186
  7. [10]Koczwara K Bonifacio E Ziegler AG 2004 Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes Diabetes 53 1 4 14693690
  8. [11]Lynch KF Lernmark B Merlo J Cilio CM Ivarsson SA Lernmark A 2008 Cord blood islet autoantibodies and seasonal association with the type 1 diabetes high-risk genotype Journal of perinatology 28 211 217 18273032
  9. [12]Ulm K 1990 A simple method to calculate the confidence interval of a standardized mortality ratio (SMR) American journal of epidemiology 131 373 375 2296988
  10. [13]O’Leary LA Dorman JS LaPorte RE 1991 Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies? Diabetes Res Clin Pract 14 183 190 1778111
  11. [14]Dahlquist G Blom L Holmgren G 1985 The epidemiology of diabetes in Swedish children 0–14 years--a six-year prospective study Diabetologia 28 802 808 3878809
  12. [15]Graham J Hagopian WA Kockum I 2002 Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes Diabetes 51 1346 1355 11978629
  13. [16]Mäkinen A Härkönen T Ilonen J Knip M 2008 Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes European journal of endocrinology 159 19 26 18573919
  14. [17]Vermeulen I Weets I Asanghanwa M 2011 Contribution of antibodies against IA-2beta and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age Diabetes Care 34 1760 1765 21715527 PMC3142046
  15. [18]Torn C Hadley D Lee HS 2014 Role of type 1 diabetes associated SNPs on risk of autoantibody positivity in the TEDDY Study Diabetes 10.2337/db14-1497 PMC4407865 25422107 · DOI

Cited by

Sorted by citations

Authors
the TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., Toppari, J., Ziegler, A.-G., Akolkar, B., & Bonifacio, E.
Affiliations
  • University of South Florida (US)
  • University of Turku (FI)
  • Pacific Northwest Research Institute (US)
  • Augusta University (US)
  • Turku University Hospital (FI)
  • TUM Klinikum (DE)
  • National Institute of Diabetes and Digestive and Kidney Diseases (US)
  • Center for Regenerative Therapies Dresden (DE)
Corresponding author
Krischer, Jeffrey P.
Venue
Diabetologia
Published
2015-02-10
Volume
58
Issue
5
Pages
980-987
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W2051883261
Cited by
444
References
3
Citations by year
2026: 33 · 2025: 42 · 2024: 40 · 2023: 44 · 2022: 37 · 2021: 45 · 2020: 39 · 2019: 30 · 2018: 45 · 2017: 39 · 2016: 35 · 2015: 14 · 2012: 1
FWCI
30.47
Type
journal article
Language
en
Open access
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • Site cant be reached (submittedVersion)
  • PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion)
Funders
  • National Institutes of Health (UL1TR001427, UL1TR000064, UL1TR001082)
  • Centers for Disease Control and Prevention
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases (UC4DK063861, HHSN267200700014C, U01 DK63865, U01DK063863, UC4DK095300, UC4DK100238, UC4DK063821, UC4DK063836, U01DK063836, UC4DK63829, UC4DK63836, UC4 DK63865, U01DK63836, U01-DK-63821, U01DK063861, U01DK063865, UC4 DK63821, UC4-DK-63863, U01DK63829, UC4DK95300, UC4-DK-63861, U01DK63861, U01-DK-63790, UC4DK063863, U01 DK63863, UC4DK063829, UC4DK063865, U01DK063821, U01DK063829, U01DK063790)
  • National Institute of Environmental Health Sciences
  • National Institute of Child Health and Human Development
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
type 1 diabetes, islet autoantibodies, insulin autoantibodies, glutamic acid decarboxylase antibodies, TEDDY study
MeSH terms
Autoantibodies, Child, Child, Preschool, Diabetes Mellitus, Type 1, Female, Genotype, HLA-DQ Antigens, Humans, Insulin, Islets of Langerhans, Male, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review